Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Foghorn Therapeutics Inc. | 300,000 | reported | 30 Jan 2026 | tx 12+806,250−26,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jan 2026 | GRANT_AWARD | Foghorn Therapeutics Inc. | 300,000 | 5.71 USD | deriv |
| 22 Jan 2025 | GRANT_AWARD | Foghorn Therapeutics Inc. | 140,000 | 4.37 USD | deriv |
| 09 Sept 2024 | SALE | Foghorn Therapeutics Inc. | 20,000 | 9.50 USD | |
| 24 Jan 2024 | GRANT_AWARD | Foghorn Therapeutics Inc. | 110,000 | 3.06 USD | deriv |
| 26 Jan 2023 | GRANT_AWARD | Foghorn Therapeutics Inc. | 100,000 | 0.00 USD | deriv |
| 11 Aug 2022 | EXERCISE | Foghorn Therapeutics Inc. | 1,858 | 3.72 USD | |
| 11 Aug 2022 | EXERCISE | Foghorn Therapeutics Inc. | 1,858 | 0.00 USD | deriv |
| 25 May 2022 | EXERCISE | Foghorn Therapeutics Inc. | 675 | 0.73 USD | |
| 25 May 2022 | EXERCISE | Foghorn Therapeutics Inc. | 3,717 | 3.72 USD | |
| 25 May 2022 | EXERCISE | Foghorn Therapeutics Inc. | 675 | 0.00 USD | deriv |
| 25 May 2022 | EXERCISE | Foghorn Therapeutics Inc. | 3,717 | 0.00 USD | deriv |
| 26 Jan 2022 | GRANT_AWARD | Foghorn Therapeutics Inc. | 150,000 | 0.00 USD | deriv |